Agenus (AGEN) Other Non-Current Assets (2010 - 2026)
Agenus (AGEN) posted quarterly Other Non-Current Assets of $3.0 million for Q1 2026, down 46.23% year-over-year from $5.6 million in Q1 2025, and down 8.89% quarter-over-quarter from $3.3 million in Q4 2025.
Analysis
Agenus (AGEN) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Agenus' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 46.23% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 46.23% YoY), while the FY2025 annual figure was $3.3 million, down 43.32% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $3.0 million, down from $3.3 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $12.5 million in Q1 2022, with the low at $3.0 million in Q1 2026.
- The 5-year median for Other Non-Current Assets is $6.6 million (2024), against an average of $6.7 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 199.12% in 2022, then slumped 64.74% in 2023.
- Agenus' Other Non-Current Assets stood at $4.5 million in 2022, then surged by 109.66% to $9.3 million in 2023, then tumbled by 37.51% to $5.8 million in 2024, then slumped by 43.32% to $3.3 million in 2025, then declined by 8.89% to $3.0 million in 2026.
- Business Quant data shows AGEN's Other Non-Current Assets at $3.0 million in Q1 2026, $3.3 million in Q4 2025, and $3.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Agenus | 342.07 Mn | 342.07 Mn | 34.52 Mn | 3.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.86 Mn |
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 6.99 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 9.34 Mn |
| Sep 30, 2023 | 11.06 Mn |
| Jun 30, 2023 | 9.26 Mn |
| Mar 31, 2023 | 4.42 Mn |
| Dec 31, 2022 | 4.45 Mn |
| Sep 30, 2022 | 7.92 Mn |
| Jun 30, 2022 | 7.92 Mn |
| Mar 31, 2022 | 12.53 Mn |
| Dec 31, 2021 | 9.54 Mn |
| Sep 30, 2021 | 14.19 Mn |